Crossmark

The Heidelberg Milestones Communication Approach (MCA) for patients with prognosis <12 months: protocol for a mixed-methods study including a randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s13063-018-2814-1

Published Online: 2018-08-14

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Siegle, Anja https://orcid.org/0000-0002-0164-9931
Villalobos, Matthias

Bossert, Jasmin

Krug, Katja

Hagelskamp, Laura

Krisam, Johannes

Handtke, Violet

Deis, Nicole

Jünger, Jana

Wensing, Michel

Thomas, Michael
Funding

Funding for this research was provided by:

Bundesministerium für Gesundheit (1504-54401)

National Center for Tumor Diseases (G835)
License Information

Text and Data Mining valid from 2018-08-14
More Information

Article History

Received: 26 April 2018

Accepted: 18 July 2018

First Online: 14 August 2018

Ethics approval and consent to participate

: See attachment “Confirmation Approval” of the Ethics Committee of the University Hospital Heidelberg, Germany (Additional file ).

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below